Category: New England Journal of Medicine

Clinical Trial Transparency — Antidote to Weaker Off-Label-Promotion Rules?

New England Journal of Medicine By Kevin Outterson, School of Law This year promises to be an auspicious period for some long-running battles over the dissemination of biomedical research. Some companies seeking more freedom to promote their products have bristled at recent guidance documents from the Food and Drug Administration (FDA) regarding promotion of drugs […]

Limiting “Sugary Drinks” to Reduce Obesity — Who Decides?

New England Journal of Medicine By Wendy Mariner, School of Public Health, School of Law By George Annas, School of Public Health When a judge struck down the New York City Board of Health’s partial ban on selling “sugary drinks” in containers of more than 16 fluid ounces, the reaction was swift… View full article